Impairment Testing Leadership Director

The mandate

The Interim Director will take control of an impairment-testing cycle whose evidence, assumptions and governance need immediate strengthening before the next annual assessment. The assignment covers scoping, indicator review, model challenge, accounting documentation and handover. It does not confer ownership of business forecasts or replace valuation specialists retained for independent technical input.

Within the first three weeks, the Director will confirm the asset and cash-generating-unit population, trace prior conclusions to current facts and establish a decision calendar. Authority includes requiring assumption owners to provide evidence, returning incomplete models, commissioning sensitivity cases within approved resources and escalating unresolved contradictions. Final accounting conclusions remain with the Group Controller.

The interim must connect accounting judgment to the underlying evidence chain. Forecasts will be reconciled to approved plans; long-term assumptions will be compared with observable support; allocation and carrying-value decisions will be documented; and headroom claims will be tested against plausible downside combinations. Where inputs are owned outside finance, accountability will be named rather than absorbed into the model.

After the principal testing cycle, the Director will convert lessons into a reusable indicator protocol, evidence standard and model-review checklist. A designated internal owner will lead an interim indicator assessment and a refreshed sensitivity review under observation. Handover is accepted only when that owner can explain the conclusion, limitations and triggers for reopening it.

The remit excludes strategic plan approval, valuation-provider procurement, transaction valuation, tax modelling and systems implementation. Any material disagreement will be preserved in the issue record with its resolution owner. The interim’s objective is a defensible process and stronger internal judgment, not the production of a predetermined impairment outcome.

What you will own

• Validate the testing perimeter, unit allocation and indicator population against current facts and approved accounting policy.
• Establish an evidence calendar linking each significant assumption to its accountable provider, reviewer and challenge date.
• Reconcile model forecasts to approved planning information and explain every material adjustment made for accounting purposes.
• Direct sensitivity and scenario analysis that exposes interacting assumptions rather than isolated mechanical changes.
• Require transparent documentation of headroom, downside, contrary evidence, limitations and reconsideration triggers.
• Present unresolved judgments and a recommended conclusion to the designated accounting authority before the reporting deadline.
• Convert cycle findings into a repeatable impairment-indicator and annual-testing protocol.
• Train and assess an internal owner through a live follow-up review and formal reverse handover.

Candidate qualifications

• Demonstrate leadership of impairment testing under IFRS or US GAAP where assumptions faced serious internal or assurance challenge.
• Describe how you reconciled an accounting model with a planning case without allowing management optimism to pass untested.
• Show mastery of unit identification, asset allocation, carrying amount, discount rates, terminal assumptions and sensitivity presentation.
• Provide an example in which interacting downside assumptions changed the governance discussion or accounting conclusion.
• Evidence independence from a preferred result and the ability to preserve contrary evidence in decision papers.
• Explain how you coordinated forecast owners and valuation specialists while retaining accounting ownership.
• Show a completed handover in which an internal leader independently reopened or defended a prior conclusion.

Working terms and boundaries

• The ten-month term covers one principal testing cycle, control redesign and an internally led follow-up assessment.
• The day rate assumes five days weekly and includes normal hybrid attendance; exceptional travel requires approval.
• Forecast creation, strategy approval and specialist valuation opinions remain outside the Interim Director’s authority.
• A two-month extension is possible only for a documented owner-validation gap, not to revisit an accepted outcome.
• Success is judged by evidence and process integrity, never by avoiding or creating an impairment charge.

Application

Applications for this mandate are received in one way only: through the India Board Terminal's application process. It is automated end to end. Your Executive Passport travels to the mandate holder in its confidential form, your answers to the three questions below are read before anything else in your file, and every stage that follows is recorded on your applications page.

There is no address to write to and no intermediary to call. The mandate holder reads what the Terminal delivers and nothing else, which is what keeps the process the same for every applicant and keeps your name out of it until you release it. Applications close on 10 October 2026. Mandate reference FNA-INT-2026-JNB-14.